![Kevin Chow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Chow
Corporate Officer/Principal chez
ALSP ORCHID ACQUISITION CORPORATION I
Profil
Kevin Chow is the founder of Vitaeris, Inc., founded in 2016, where the titles held included President, Chief Executive Officer & Director from 2016 to 2020.
Dr. Chow is also the founder of Mitera Biosciences, Inc...
Dr. Chow is currently Operating Partner at Accelerator Services Corp since 2020.
Dr. Chow is President & Chief Operating Officer at Incisive Genetics, Inc. since 2021.
Dr. Chow is Chief Business Officer at ALSP Orchid Acquisition Corp.
I.
Former positions include Director-Business Development at Corus Pharma, Inc. Senior Director & Head-Business Development and Director at Lundbeck Seattle BioPharmaceuticals, Inc. from 2009 to 2016.
Education includes undergraduate (1992), graduate (1996), and doctorate (1999) degrees from the University of British Columbia.
Postes actifs de Kevin Chow
| Sociétés | Poste | Début |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Corporate Officer/Principal | - |
Incisive Genetics, Inc.
 Incisive Genetics, Inc. BiotechnologyHealth Technology Manufactures genetic medicines | President | 07/06/2021 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01/09/2020 |
Anciens postes connus de Kevin Chow
| Sociétés | Poste | Fin |
|---|---|---|
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Fondateur | 01/08/2020 |
| ALDER BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 30/07/2016 |
| ALDER BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/06/2016 |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Corporate Officer/Principal | - |
Formation de Kevin Chow
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
Incisive Genetics, Inc.
Incisive Genetics, Inc. BiotechnologyHealth Technology Manufactures genetic medicines | Health Technology |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
